Collegium Pharmaceutical Inc. (NASDAQ: COLL) announced it will acquire AZSTARYS, an attention deficit hyperactivity disorder treatment, from privately held Corium ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions